Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of IgPro10 in Chronic ITP
NCT00168038Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Dec 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in immune thrombocytopenic purpura (ITP), sponsored by CSL Limited. Started Dec 2004; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00168038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168038.